tiprankstipranks
Arca Biopharma (ABIO)
NASDAQ:ABIO

Arca Biopharma (ABIO) Stock Price & Analysis

467 Followers

ABIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.56 - $4.49
Previous Close$3.2
Volume12.97K
Average Volume (3M)1.46M
Market Cap
$47.13M
Enterprise Value$9.20M
Total Cash (Recent Filing)$37.43M
Total Debt (Recent Filing)$204.00K
Price to Earnings (P/E)
Beta>-0.01
Jul 31, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding14,507,143
10 Day Avg. Volume81,936
30 Day Avg. Volume1,460,604
Standard Deviation0.36
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ABIO FAQ

What was Arca Biopharma’s price range in the past 12 months?
Arca Biopharma lowest stock price was $1.56 and its highest was $4.49 in the past 12 months.
    What is Arca Biopharma’s market cap?
    Currently, no data Available
    When is Arca Biopharma’s upcoming earnings report date?
    Arca Biopharma’s upcoming earnings report date is Jul 31, 2024 which is in 49 days.
      How were Arca Biopharma’s earnings last quarter?
      Arca Biopharma released its earnings results on Apr 25, 2024. The company reported -$0.138 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.138.
        Is Arca Biopharma overvalued?
        According to Wall Street analysts Arca Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Arca Biopharma pay dividends?
          Arca Biopharma does not currently pay dividends.
          What is Arca Biopharma’s EPS estimate?
          Arca Biopharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Arca Biopharma have?
          Arca Biopharma has 14,507,143 shares outstanding.
            What happened to Arca Biopharma’s price movement after its last earnings report?
            Arca Biopharma reported an EPS of -$0.138 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.874%.
              Which hedge fund is a major shareholder of Arca Biopharma?
              Among the largest hedge funds holding Arca Biopharma’s share is Western Standard Llc. It holds Arca Biopharma’s shares valued at 2M.
                ---

                Arca Biopharma Stock Smart Score

                7
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                59.22%
                12-Months-Change

                Fundamentals

                Return on Equity
                -15.87%
                Trailing 12-Months
                Asset Growth
                -12.73%
                Trailing 12-Months

                Company Description

                Arca Biopharma

                ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Arbutus Biopharma
                Acasti Pharma
                Advaxis
                Cellectar Biosciences
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis